Xtant Medical (NYSE:XTNT) said that CEO Dan Goldberger resigned effective Jan. 21 “to pursue other interests.”
The Belgrade, Mont.-based company, which was formed after Bacterin paid $86 million for spinal implant maker X-Spine Systems, said president Carl O’Connell will step in as interim CEO while the company’s board “contemplates the permanent CEO,” according to a press release.
“We are thankful for Dan’s significant contributions to the Company during his tenure as chief executive. Under Dan’s leadership, the company has made significant progress toward our strategic goals,” chairman Kent Swanson said in prepared remarks. “We are fortunate to have Carl O’Connell agree to serve as interim CEO. Carl is an accomplished senior executive with a demonstrated history of leading marketing and sales organizations and deep healthcare and medical device experience. We look forward to working with Carl as we embark on the next phase of the company’s growth.”
RIP Sequana Medical founder & CEO Johnson
Sequana Medical said founder, president and CEO Noel Johnson, died suddenly last month.
Johnson founded Sequana in 2006 based on his idea for a fully implantable, battery-powered pump to treat refractory ascites, or chronic fluid build-up in the abdomen, the company said in a Dec. 22 press release.
“The board and all employees are greatly saddened by Noel’s passing, and indebted to Noel for his boundless energy and dedication, and significant contribution to Sequana Medical. Throughout his time with Sequana Medical, Noel was dedicated to improving the quality of life of patients living with this debilitating disease. The availability of the Alfapump system for refractory ascites patients in Europe is due in great part of Noel’s hard work and commitment. The board’s thoughts are with Noel’s family at this difficult time,” the company said.
Johnson had already begun to process of handing over the reins to Ian Crosbie, who was named CFO in July 2016. Read more
Guided Therapeutics (OTC:GTHP) said it tapped co-founder and former CEO Mark Faupel to be its new COO and named him to a seat on the board. Read more
Reflexion Health said it named Sudipto Sur, the former chief technology officer at Signal Genetics, as its CTO effective Jan. 3. Read more
ResMed (NYSE:RMD) said it named Dr. Carlos Nunez, the former SVP of medical affairs for Becton Dickinson & Co. (NYSE:BDX), to be its chief medical officer, effective Jan. 3. Read more
- Valeritas promotes Nguyen to CCO
- Titan Spine taps Bird as CCO
- Spectranetics names Medtronic vet Hutton as vascular intervention GM
- AdvaMed makes O’Connor VP for alliance development
- AHCA alum Crist tapped for public affairs EVP post at AdvaMed